The antibody-drug conjugate trastuzumab deruxtecan (T-DXd, Enhertu) proved active in a phase II study of advanced HER2-positive colorectal cancer (CRC). Almost 40% of patients treated with the ...

New analysis of the DESTINY-Breast06 trial demonstrated that trastuzumab deruxtecan (T-DXd) provides meaningful clinical benefit regardless of time to progression on prior endocrine therapy, offering ...

The whole thing went live on social media as High School DxD celebrated its next series. On May 17th, Junior High School DxD – The Transfer Student is a Samurai Girl will go live. We learned about the ...

Meet Dev, an avid writer, cat lover, and anime enthusiast. He has a passion for storytelling, traveling, and new adventures. High School DxD is a captivating ecchi anime with action, romance, and ...

When Merck & Co. and Daiichi Sankyo last year received an FDA complete response letter for their HER3-directed antibody-drug conjugate (ADC) patritumab deruxtecan, the companies hoped to address ...

With recent expansions in its breast cancer indications, there has been an increase in the use of trastuzumab deruxtecan (T-DXd; Enhertu). "A lot of us are using this more frequently now than we were ...

What Is High School DxD? This crossover between High School DxD and VTuber Legend: How I Went Viral After Forgetting to Turn Off My Stream goes to a whole new level as High School DxD’s first three ...

A new BLA for Dato-DXd targets EGFR-mutated NSCLC, following withdrawal of a previous application based on TROPION-Lung01 trial data. The new submission is supported by phase 2 TROPION-Lung05 trial ...

BO-112 Plus Pembrolizumab for Patients With Anti–PD-1–Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203 Patients with advanced squamous or nonsquamous NSCLC without a common ...